PharmaShots Weekly Snapshot (January 27-31, 2020)

  1. ProQR’s QR-421a Receives FDA’s Rare Pediatric Disease Designation for Retinitis Pigmentosa

Published: Jan 30, 2020 | Tags: ProQR, QR-421a, Receives, FDA, Rare Pediatric Disease Designation, Retinitis Pigmentosa

2. Eli Lilly’s Fast-Acting Insulin Lispro Receives CHMP’s Positive Opinion in Patients with Diabetes

Published: Jan 31, 2020 | Tags: Eli Lilly, Fast Acting Insulin Lispro, Receives, CHMP, Positive Opinion, Patients, Diabetes

3. Alnylam’s Givlaari (givosiran) Receives CHMP’s Positive Opinion to Treat Acute Hepatic Porphyria in Adults and Adolescents

Published: Jan 31, 2020 | Tags: Alnylam, Givlaari, givosiran, Receives, CHMP, Positive Opinion, Treat, Acute Hepatic Porphyria, Adults, Adolescents

4. Accenture Collaborates with Google Cloud to Support Life Sciences Companies Advancing Research and Development of Innovative Therapies

Published: Jan 30, 2020 | Tags: Accenture, Collaborates, Google Cloud, Support, Life Sciences Companies, Research, Development, Innovative Therapies

5. Microsoft Launches $40M AI Program to Accelerate Health Initiatives Globally

Published: Jan 29, 2020 | Tags: Microsoft, Launches, $40M, AI Program, Accelerate, Health Initiatives, Globally

6. Abbott’s Tendyne Receives CE Mark as the World’s First Transcatheter Mitral Valve Implantation System in Europe

Published: Jan 30, 2020 | Tags: Abbott, Tendyne, Receives, CE Mark, World, First, Transcatheter Mitral Valve Implantation System, Europe

7. Inovio Collaborates with Beijing Advaccine to Advance the Development of INO-4800 Vaccine Targeting Coronavirus in China

Published: Jan 30, 2020 | Tags: Inovio, Collaborates, Beijing Advaccine, Advance, Development, INO-4800, Vaccine, Targeting Coronavirus, China

8. Spring Bank Discontinues the Development of Inarigivir to Treat Patients with Chronic Hepatitis B Virus

Published: Jan 29, 2020 | Tags: Spring Bank, Discontinues, Development, Inarigivir, Chronic Hepatitis B Virus

9. Bayer Report Result of Nubeqa (darolutamide) + ADT in P-III ARAMIS Study for Non-Metastatic Castration-Resistant Prostate Cancer

Published:  Jan 30, 2020 | Tags: Bayer, Report, Result, Nubeqa, darolutamide, ADT, P-III, ARAMIS Study, Non-Metastatic Castration-Resistant Prostate Cancer

10. Janssen Receives EC’s Approval for Expanded Use of Erleada (apalutamide) to Treat Metastatic Hormone-Sensitive Prostate Cancer

Published: Jan 29, 2020 | Tags: Janssen, Receives, EC, Approval, Expanded Use, Erleada, apalutamide, Metastatic, Hormone-Sensitive Prostate Cancer

11. Sorrento Collaborates with Celularity to Initiate the Development of Emergency Allogeneic Natural Killer Cell Therapy for Coronavirus Infection

Published: Jan 30, 2020 | Tags: Sorrento, Collaborates, Celularity, Initiate, Development, Emergency, Allogeneic Natural Killer Cell Therapy, Coronavirus Infection

12. Astellas Reports Submission of sNDA to MHLW for Evrenzo (roxadustat) to Treat Anemia Associated with Chronic Kidney Disease in Non-Dialysis Dependent Patients in Japan

Published: Jan 30, 2020 | Tags: Astellas, Reports, Submission, sNDA, MHLW, Evrenzo, roxadustat, Anemia; Associated; Chronic Kidney Disease, Non-Dialysis Dependent, Patients, Japan

13. Sanofi Reports Results of Olipudase alfa in Two Studies for Acid Sphingomyelinase Deficiency in Adults and Pediatric Patients

Published: Jan 30, 2020 | Tags: Sanofi, Reports, Results, Olipudase alfa, Two Studies, Acid Sphingomyelinase Deficiency, Adults, Pediatric Patients

14. Johnson & Johnson Initiates the Development of Vaccines Against Coronavirus

Published: Jan 29, 2020 | Tags: Johnson & Johnson, Initiates, Development, Vaccines, Coronavirus

15. Akcea and Ionis Report Results of AKCEA-ANGPTL3-LRx in P-II Study for Patients with Cardiovascular and Metabolic Diseases

Published: Jan 28, 2020 | Tags: Akcea, Ionis, Report, Results, AKCEA-ANGPTL3-LRx, P-II, Study, Patients, Cardiovascular, Metabolic Diseases

16. Verastem Reports Dosing of Copiktra (duvelisib) in CPSC’s Chinese Study for Relapsed or Refractory Follicular Lymphoma

Published: Jan 29, 2020 | Tags:  Verastem, Reports, Dosing, Copiktra, duvelisib, CPSC, Chinese Study, Relapsed, Refractory, Follicular Lymphoma

17. Eli Lilly’s Selpercatinib (LOXO-292) Receives Priority Review Status for the Treatment of RET-Driven Cancer Indications

Published: Jan 29, 2020 | Tags: Eli Lilly, Selpercatinib, LOXO-292, Receives, Priority Review Status, Treatment, RET-driven Cancer Indications

18. Kite Reports the Validation of EMA’s MAA for KTE-X19 to Treat Relapsed or Refractory Mantle Cell Lymphoma

Published: Jan 28, 2020 | Tags: Kite, Reports, Validation, EMA, MAA, KTE-X19, Treat, Relapsed, Refractory, Mantle Cell Lymphoma

19. Takeda Report Submission of NDA to MHLW for Cabometyx (cabozantinib) to Treat Advanced Hepatocellular Carcinoma in Japan

Published: Jan 29, 2020 | Tags: Takeda, Report, Submission, NDA, MHLW, Cabometyx, cabozantinib, Treat, Advanced Hepatocellular Carcinoma, Japan

20. Timber Pharmaceuticals Signs a Reverse Merger Agreement with BioPharmX

Published: Jan 28, 2020 | Tags: Timber Pharmaceuticals, Signs, Reverse Merger Agreement, BioPharmX

21. Alkermes Reports the US FDA Acceptance of NDA for ALKS 3831 to Treat Schizophrenia and Bipolar I Disorder

Published: Jan 28, 2020 | Tags: Alkermes, Reports, US, FDA, Acceptance, NDA, ALKS 3831, Treat, Schizophrenia, Bipolar I Disorder

22. Ningbo NewBay Medical Technology Signs an Exclusive License Agreement with Genentech to Develop and Commercialize GDC-0570

Published: Jan 27, 2020 | Tags: Ningbo NewBay Medical Technology, Signs, Exclusive, License Agreement, Genentech, Develop, Commercialize, GDC-0570

23. Bausch + Lomb Collaborates with TerraCycle to Launch First Contact Lens Recycling Program in Canada

Published: Jan 27, 2020 | Tags: Bausch + Lomb, Collaborates, TerraCycle, Launch, First, Contact Lens Recycling Program, Canada

24. Eli Lilly and Boehringer Ingelheim’s Triple Regimen Receive the US FDA’s Approval for Type 2 Diabetes

Published: Jan 27, 2020 | Tags:  Eli Lilly, Boehringer Ingelheim, Triple Regimen, Receive, US, FDA, Approval, Type 2 Diabetes

25. GSK Out Licenses its Tuberculosis Vaccine (M72/AS01E ) to Bill & Melinda Gates Medical Research Institute

Published: Jan 27, 2020 | Tags: GSK, Out Licenses, Tuberculosis Vaccine (M72/AS01E ), Bill & Melinda Gates Medical Research Institute

26. Sanofi and Regeneron Receive the US FDA’s Priority Review Acceptance for Dupixent’s sBLA to Treat Moderate-to-Severe Atopic Dermatitis in Children Aged 6 to 11 Years

Published: Jan 28, 2020 | Tags: Sanofi, Regeneron, Receive, FDA, Priority Review Acceptance, Dupixent, sBLA, Moderate-to-Severe Atopic Dermatitis, Aged 6 to 11 Years 

27. Merck & Co’s Dificid (fidaxomicin) Receives FDA’s Approval to Treat Clostridioides difficile in Children Aged Six Months and Older

Published: Jan 27, 2020 | Tags: Merck & Co’s, Dificid, fidaxomicin, Receives, FDA, Approval, Treat, Clostridioides difficile, Children, Aged, Six Months and Older

28. AstraZeneca Reports Results of Brilinta (ticagrelor) in P-III THALES Study for Patients with Minor Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Published: Jan 27, 2020 | Tags: AstraZeneca, Reports, Results, Brilinta, ticagrelor, P-III, THALES Study, Patients, Minor Acute Ischemic Stroke, High-Risk Transient Ischemic Attack

29. Roche Reports Submission of sBLA to the US FDA for Tecentriq (atezolizumab) + Avastin (bevacizumab) to Treat Unresectable Hepatocellular Carcinoma

Published: Jan 27, 2020 | Tags: Roche, Reports, Submission, sBLA, US, FDA, Tecentriq, atezolizumab, Avastin, bevacizumab, Treat, Unresectable Hepatocellular Carcinoma

30. AstraZeneca to Divest its Hypertension Therapies to Atnahs Pharma

Published: Jan 27, 2020 | Tags: AstraZeneca, Divest, Hypertension Therapies, Atnahs Pharma

31. AbbVie to Divest Allergan’s Brazikumab and Zenpep (pancrelipase) to Gain the US FTC and EC’s Approval on Pending Allergan Acquisition

Published: Jan 27, 2020 | Tags: AbbVie, Divest, Allergan, Brazikumab, Zenpep, pancrelipase, Gain, US, FTC, EC, Approval, Pending Allergan Acquisition

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post